The Genome as Commons
By Tom Athanasiou and Marcy Darnovsky,
WorldWatch
| 07. 01. 2002
Through all the trials and tribulations of human history what binds us in the end is our common humanity
July/August 2002
The atmosphere. The oceans and fresh waters. The land itself, and the fruits and grains our forebears bred and cultivated upon it. The broadcast spectrum. The attention spans of our children.
Does such a list adequately evoke "the commons," and the stakes we face in trying to save it—both for itself and as the foundation of our common future? Or must we add yet another, more shocking example? Perhaps we must put the human genome itself on this endangered commons list, and note that if this genetic commons too is lost to partition and privatization, if it too becomes the privilege of the affluent, then none of us on either side of the divide can be sure of retaining the "humanity" we like to think we've achieved.
The biotech boosters, of course, don't see things this way. Many of them insist that any conceivable application of human genetic engineering is essential to medical progress, and that the possibilities, no matter how speculative, trump all other considerations. Thus they shrug off the likely outcome of embryo cloning—that it will...
Related Articles
By Staff [cites CGS' Katie Hasson], Radio New Zealand | 04.05.2025
At a time where some countries are struggling with low birth rates, the voices for pronatalism are getting louder. But it’s who’s sounding the call for more babies that has people talking.
Tech giant Elon Musk has fourteen children and...
By Amanda Hess, The New York Times | 04.05.2025
Image "Elon Musk" by Debbie Rowe on Wikimedia Commons licensed under CC by S.A. 3.0
For months, an internet-wide guessing game has swirled around the question of where Elon Musk’s intelligence falls on the bell curve. President Trump has called...
By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi, MIT Technology Review | 03.25.2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...